Mechanome Bio

Mechanome Bio is a Cambridge-based company developing a mechano-transcriptomics platform for biomarker and drug target discovery.

The platform combines spatial multi-omics data from human tissue samples with mechanical tissue profiling and in silico tissue modelling to identify targets linked to changes in tissue mechanical states in disease.

The approach aims to address preclinical efficacy failures by incorporating tissue-scale mechanical signatures into drug development from the earliest stages.